Meeshanthini Dogan
Director Ejecutivo en CARDIO DIAGNOSTICS HOLDINGS, INC. .
Fortuna: 1 M $ al 31/05/2024
Perfil
Meeshanthini V.
Dogan is the founder of Cardio Diagnostics, Inc. which was founded in 2017.
She holds the title of Chief Executive Officer & Director at the company.
Currently, she is also the Chief Executive Officer & Director at Cardio Diagnostics Holdings, Inc. since 2022.
Dr. Dogan has an education background from the University of Iowa, with degrees in undergraduate, graduate, and doctorate studies.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
01/04/2024 | 1 586 464 ( 6.99% ) | 1 M $ | 31/05/2024 |
Cargos activos de Meeshanthini Dogan
Empresas | Cargo | Inicio |
---|---|---|
CARDIO DIAGNOSTICS HOLDINGS, INC. | Director Ejecutivo | 25/10/2022 |
Cardio Diagnostics, Inc.
Cardio Diagnostics, Inc. Medical/Nursing ServicesHealth Services Part of Cardio Diagnostics Holdings, Inc., Cardio Diagnostics, Inc. is a biotechnology company based in Chicago, IL. The company is focused on making cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company's flagship solution, the Cardio Diagnostics Epi+Gen CHD™ test, helps clinicians better assess each patient's unique risk profile for disease. The company's vision is to transform medical care for cardiovascular disease from reactive to proactive. Cardio Diagnostics was founded in 2017 by Meeshanthini Dogan and Robert Philibert, with Meeshanthini Dogan serving as CEO since then. Cardio Diagnostics was acquired by Mana Capital Acquisition Corp. on October 25, 2022 for $61.51 million. | Fundador | 01/05/2017 |
Formación de Meeshanthini Dogan.
University of Iowa | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
CARDIO DIAGNOSTICS HOLDINGS, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Cardio Diagnostics, Inc.
Cardio Diagnostics, Inc. Medical/Nursing ServicesHealth Services Part of Cardio Diagnostics Holdings, Inc., Cardio Diagnostics, Inc. is a biotechnology company based in Chicago, IL. The company is focused on making cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company's flagship solution, the Cardio Diagnostics Epi+Gen CHD™ test, helps clinicians better assess each patient's unique risk profile for disease. The company's vision is to transform medical care for cardiovascular disease from reactive to proactive. Cardio Diagnostics was founded in 2017 by Meeshanthini Dogan and Robert Philibert, with Meeshanthini Dogan serving as CEO since then. Cardio Diagnostics was acquired by Mana Capital Acquisition Corp. on October 25, 2022 for $61.51 million. | Health Services |
- Bolsa de valores
- Insiders
- Meeshanthini Dogan